Beta: Sign in
Shares outstandingAs of 2026-08-27 · filed common shares: 64.30M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 0.14%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 8.09%
Short ratioDays to cover, as published by FINRA: 5.81
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 31.00%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 30.30%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross margin: —
Operating marginFY Jun 26: -35141.00%
Net margin: —
EBITDA marginFY Jun 26: -34495.00%
Return on equityNet income (FY Jun 26) ÷ average shareholders equity: -65.70%
Return on assetsNet income (FY Jun 26) ÷ average total assets: -54.04%

Growth

Revenue growth (annual YoY): -75.00%
Revenue growth (latest qtr YoY): -100.00%
Revenue growth (fwd): Sign in
Net income growth (annual YoY): —
Net income growth (latest qtr YoY): —
EPS growth (fwd): Sign in
Net income growth (QoQ): —

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, FY Jun 26

-0.32

EPS (fwd)

Financial health

Cash & equivalentsas of Jun 26: $56.39M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $2.19M
Debt / equityas of Jun 26: 2.56%
Current ratioas of Jun 26: 7.85
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Sep 25: 8.21
Operating cash flowFY Jun 26: -$23.21M
Free cash flowUnadjusted FCF = CFO − capex · FY Jun 26: -$23.79M
TTM revenue / diluted shareDiluted, FY Jun 26: 0.00

IBIO stock Statistics — iBio, Inc. filings, insiders & smart money · Instaport